On 3 February 2025, on the eve of World Cancer Day, Cancer Patients Europe (CPE) hosted a high-level policy event at the European Parliament in Brussels, convened by MEP Michalis Hadjipantela (EPP,…
Sixteen years ago, Dr. Michael Gnant was portrayed in CancerWorld as a surgical oncologist unafraid to push boundaries in breast cancer care. Today, his perspective reflects not retreat but evolution. The boundary-pusher…
In oncology, some milestones arrive with applause. Others arrive quietly. This year, one of the most important cancer drugs of the modern era begins to lose its monopoly. Nivolumab, one of the…
In oncology today, innovation advances at a breathtaking pace, yet the capacity to deliver it to all who need it lags behind. Each new therapeutic frontier exposes the same paradox: the deeper…
When the first signals of modern immunotherapy began to emerge a little over a decade ago, many of us realised that oncology was about to change forever. I still remember the sense…
In May 2025, neuroscientist Frank Winkler, together with neurooncologist Michelle Monje, received the Brain Prize for pioneering Cancer Neuroscience, a discipline that explores how neurons actively contribute to tumor growth. How are…
Sodium-glucose cotransporter 2 (SGLT2) inhibitors, a common type of diabetes medication, may protect the heart during and after cancer treatment. The systematic review and meta-analysis, published in European Journal of Preventive Cardiology…
It is often said in medicine that the only true constant in facing life-threatening diseases is change. Nowhere is this more evident than in oncology, where advances in chemotherapy, targeted therapies, immunotherapies,…
Throughout human history, the search for a universal cure has captivated the minds of philosophers, healers and scientists across time and cultures. In Greek mythology, the goddess Panacea was believed to possess…
Over the past 10 years, immune checkpoint inhibitors (ICIs) have transformed the therapeutic landscape of cancer, becoming standard treatments for metastatic melanoma, renal cell carcinoma, head and neck cancer, and non-small cell…
